5/26/2022 6:49:51 AM
Pfizer Says FDA Grants Fast Track Designation For Ervogastat/Clesacostat Combination For NASH
5/25/2022 3:14:54 AM
Pfizer Launches 'An Accord For A Healthier World'
5/24/2022 6:55:33 AM
Pfizer Presents ELEVATE Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile In Ulcerative Colitis
5/23/2022 6:50:39 AM
Pfizer-BioNTech Says COVID-19 Vaccine Demonstrates Immune Response, Favorable Safety In Children 6 Months-Under 5 Yrs
5/17/2022 11:51:17 AM
Pfizer & BioNTech Gets US Emergency Use Authorization For Booster Dose Of COVID-19 Vaccine In Children 5 To 11 Years
5/10/2022 6:48:23 AM
Pfizer Agrees To Buy Biohaven For $148.50/Shr Cash
5/6/2022 7:40:51 AM
Myovant, Pfizer: FDA Extends Review Of Myfembree In Endometriosis To August 6, 2022
5/3/2022 6:55:03 AM
Pfizer Inc. (PFE) Has Lowered Its FY22 EPS Estimate To 6.25 - 6.45 From 6.35 - 6.55
5/3/2022 6:47:08 AM
Pfizer Q1 Reported EPS $1.37 And Adj EPS $1.62